| Metric | Q1 2025 | Q4 2024 | Q1 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $5.4B | — | — | — | — |
| Op. Income | $1.3B | — | — | — | — |
| Gross Margin | 26.5% | — | — | — | — |
| Net Margin | 0.5% | — | — | — | — |
| EPS (Diluted) | $0.04 | — | — | — | — |
| Free Cash Flow | -$2M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $5.4B |
| Cost of Revenue | $4.0B |
| GROSS PROFIT | $1.4B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $97M |
| SG&A Expenses | $97M |
| Other Expenses | $0 |
| Operating Expenses | $97M |
| Cost & Expenses | $4.1B |
| OPERATING INCOME | $1.3B |
| Interest Income | $0 |
| Interest Expense | $899M |
| Other Income/Expenses | -$653M |
| INCOME BEFORE TAX | $678M |
| Income Tax Expense | $152M |
| Net Income from Continuing Ops | $526M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $26M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $17M |
| D&A | $960M |
| EBIT | $1.3B |
| EBITDA | $2.3B |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $5.4B |
| Cost of Revenue | $4.0B |
| GROSS PROFIT | $1.4B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $97M |
| SG&A Expenses | $97M |
| Other Expenses | $0 |
| Operating Expenses | $97M |
| Cost & Expenses | $4.1B |
| OPERATING INCOME | $1.3B |
| Interest Income | $0 |
| Interest Expense | $899M |
| Other Income/Expenses | -$653M |
| INCOME BEFORE TAX | $678M |
| Income Tax Expense | $152M |
| Net Income from Continuing Ops | $526M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $26M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $17M |
| D&A | $960M |
| EBIT | $1.3B |
| EBITDA | $2.3B |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $26M |
| Depreciation & Amortization | $960M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $455M |
| Change in Working Capital | -$573M |
| OPERATING CASH FLOW | $868M |
| Capital Expenditure | -$870M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $766M |
| NET CASH FROM INVESTING | -$104M |
| Net Debt Issuance | -$816M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$208M |
| Other Financing Activities | -$378M |
| NET CASH FROM FINANCING | -$1.4B |
| FREE CASH FLOW | -$2M |
| Net Change in Cash | -$608M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $1.5B |
| Short-Term Investments | $301M |
| Net Receivables | $4.9B |
| Inventory | $430M |
| Other Current Assets | $743M |
| TOTAL CURRENT ASSETS | $7.8B |
| PP&E (Net) | $51.0B |
| Goodwill | $14.3B |
| Intangible Assets | $14.7B |
| Long-Term Investments | $6.2B |
| Tax Assets | $0 |
| Other Non-Current Assets | $9.7B |
| TOTAL NON-CURRENT ASSETS | $95.8B |
| TOTAL ASSETS | $103.7B |
| Account Payables | $5.2B |
| Short-Term Debt | $3.5B |
| Deferred Revenue | $0 |
| Other Current Liabilities | $829M |
| TOTAL CURRENT LIABILITIES | $10.2B |
| Long-Term Debt | $47.2B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $12.0B |
| TOTAL NON-CURRENT LIABILITIES | $63.7B |
| TOTAL LIABILITIES | $73.9B |
| Common Stock | $6.2B |
| Additional Paid-In Capital | $0 |
| Retained Earnings | -$4.2B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $2.5B |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $5.5B |
| Minority Interest | $24.3B |
| TOTAL EQUITY | $29.8B |
| TOTAL LIABILITIES & EQUITY | $103.7B |
| Total Debt | $55.8B |
| Net Debt | $54.3B |
